Skip to main content
NIH funding notice RFA-CA-24-028

Limited Competition: AIDS Malignancy Consortium (AMC; UM1 Clinical Trial Required)

Closed on January 10, 2025.

Posted
August 13, 2024
Close date
January 10, 2025
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $16,392,131 in first-year total cost, median $16,392,131.

Most frequent study sections

  1. Special Emphasis Panel[ZCA1 RPRB-L (M2)]1

Most frequent institutions

  1. ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI1
Competing awards under RFA-CA-24-028 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025Consortium for Advancing Management and Prevention of Cancer in People with HIV2UM1CA121947-19SPARANO, JOSEPH A.ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY$16,392,131ZCA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.